Andere talen BriaCell Therapeutics Corp. Nasdaq

Aandelen

BCTX

CA1079301091

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 10-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,25 ^USD	-0,44%		-0,44%	-61,54%

10/04	BriaCell 2024 AACR-preklinische poster bevestigt sterke antikankeractiviteit van Bria-OTS+? en Bria-PROS+? klinische kandidaten voor borst- en prostaatkanker	CI
09/04	BriaCell presenteert nieuwste Bria-IMT gegevens op posterpresentaties tijdens AACR 2024	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting	24/04
BriaCell Announces Oral and Poster Presentations at ASCO 2024	24/04
BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer	10/04
BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+? and Bria-PROS+? Clinical Candidates for Breast and Prostate Cancer	10/04
BriaCell to Showcase Latest Bria-IMT Data in Poster Presentations at 2024 AACR	09/04
BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR	09/04
BriaCell Therapeutics : NOTICE OF NO AUDITOR REVIEW OF THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS - Form 8-K	02/04
BriaCell Therapeutics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	18/03
BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies	07/03
BriaCell to Present Clinical Data in CNS Metastasis and Antibody-Drug Conjugate Resistant Breast Cancer at AACR Conference	06/03
BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference	06/03
BriaCell Provides Update on Alleged Illegal Trading of Public Securities	27/02
BriaCell Announces Strong Clinical Data in Breast Cancer Patients	07/02
BriaCell Therapeutics Corp. Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case	07/02
BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case	07/02
Toronto Stocks Rally; Precision Drilling Rises on 4Q Profit Growth	06/02
Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing	06/02
Briacell Therapeutics Corp. Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates Gmp Manufacturing	06/02
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting	31/01
BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with "Eye-Bulging" Metastatic Breast Cancer	04/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen BriaCell Therapeutics Corp. Nasdaq

Aandelen

BCTX

CA1079301091

Andere talen

Filters